The American Clinical Laboratory Association
The American Clinical Laboratory Association (ACLA) represents the leading independent providers of laboratory services in the United States. Through advocacy and education, ACLA informs Congress and other thought leaders about the essential role that laboratory services play in preventing, diagnosing, and managing a wide range of conditions, including diabetes, prediabetes, and the complications associated with both.
The Diabetes Advocacy Alliance™ is working to increase awareness of, and action on, the diabetes epidemic among legislators and policymakers. We are a diverse group of patient advocacy organizations, professional societies, trade associations and corporations, sharing a common goal to defeat diabetes. Explore our site to learn more about what's on the front burner in our communications with Capitol Hill and the Administration.
Campaigns/Issues
If we can use public policy to change attitudes and behavior around major public health challenges such as using seat belts or preventing the flu, we can use it to limit the societal costs of type 2 diabetes. Right now, there are 26 million Americans with diabetes and another 79 million at high risk for developing the disease. Implementing proven prevention methods could reduce the rate of diabetes and its complications, which could save thousands of lives and billions of dollars annually. Diabetes prevention is a smart investment. That's the message of a provocative advertising campaign from the DAA, and funded by DAA member Novo Nordisk. Click here to learn more and see our ads.
